Focal dermal hypoplasia (Goltz syndrome): A decreased accumulation of hyaluronic acid in three-dimensional culture

Acta Dermato-Venereologica

Volumn 76, Issue 5, 1996, Pages 365-367

  Sato, Madoka ^a   Ishikawa, Osamu ^a   Yokoyama, Yoko ^a   Kondo, Asami ^a   Miyachi, Yoshiki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GLYCOSAMINOGLYCAN; HYALURONIC ACID;

ADULT; ARTICLE; CASE REPORT; FEMALE; FIBROBLAST; GOLTZ SYNDROME; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADULT; CELLS, CULTURED; COLLAGEN; FEMALE; FIBROBLASTS; FOCAL DERMAL HYPOPLASIA; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; HYDROXYPROLINE; SKIN;

EID: 0029825041     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Goltz RW, Peterson WC, Gorlin RJ, Ravitis HG. Focal dermal hypoplasia. Arch Dermatol 1962; 86: 708-717.
2. Uitto J, Bauer EA, Santa-Cruz DJ, Loewinger RJ. Focal dermal hypoplasia: abnormal growth characteristics of skin fibroblasts in culture. J Invest Dermatol 1990; 7: 283-286.
3. Büchner SA, Itin P. Focal dermal hypoplasia syndrome in a male patient. Report of a case and histologic and immunohistochemical studies. Arch Dermatol 1992;128:1078-1082.
4. Hata R, Senoo H. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation and formation of a 3-dimensional tissue-like substance by skin fibroblasts. J Cell Physiol 1989; 138: 8-16.
5. Ishikawa O, Yokoyama Y, Miyachi Y. Disaccharide analysis of dermal fibroblast-derived glycosaminoglycans in the three-dimensional culture. J Dermatol Sci 1994; 8: 203-207.
6. Kanayama N, Terao T. Relation of serum levels of pro-type I collagen peptide. pro-type III peptide and type IV 7S collagen with cervical maturation. Gynecol Obstet Invest 1992; 34: 24-26.
7. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-447.
8. Akimoto S, Hayashi H, Ishikawa H. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 1992; 126: 29-34.
9. Higuchi T, Ohnishi K, Hayashi H, Ishikawa O, Miyachi Y. Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis. Acta Derm Venereol (Stockh) 1994; 74: 179-182.
10. Honda S, Akao E, Suzuki S, Okuda M, Kakehi K, Nakamura J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrasolone derivatives. Anal Biochem 1989; 180: 351-357.
11. Wettke R, Kanter G. X-linked dominant diseases with lethality in hemizygous males. Hum Genet 1983; 64: 1-23.
12. Kilmer SL, Grix AW Jr. Isseroff RR. Focal dermal hypoplasia: four cases with widely varying presentations. J Am Acad Dermatol 1993; 28: 839-843.
13. Howell JB, Freeman RG. Cutaneous defects of focal dermal hypoplasia: an ectodermal dysplasia syndrome. J Cutan Pathol 1989; 16: 237-258.
14. Tsuji T. Focal dermal hypoplasia syndrome. An electron microscopical study of the skin lesions. J Cutan Pathol 1982; 9: 271-281.
15. Meyer K. The biological significance of hyaluronic acid and hyaluronidase. Physiol Rev 1947; 29: 335-359.
16. Matuoka K, Namba M, Mitsui Y. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J Cell Biol 1987; 104: 1105-1115.
17. Toole BP, Goldberg RL, Chi-Rosso G, Underhill CB, Orkin RW. Hyaluronate-cell interaction. In: Trelstad RL, ed. The role of extracellular matrix in development. New York: Alan R. Liss, Inc., 1984; 43-66.
18. Higuchi T, Ishikawa O, Hayashi H, Ohnishi K, Miyachi Y. Disaccharide analysis of skin glycosaminoglycans in patients with Werner's syndrome. Clin Exp Dermatol 1994; 19: 487-491.